Past events

3.30–4.30pm 7 July 2017
Dr Amee George, Manager, Target and Drug Discovery Platform, JCSMR Dr George obtained her PhD in 2007 from the Department of Pathology at the University of Melbourne. With an interest in functional genomics, in 2008, she...
3.30–4.40pm 6 July 2017
Dr Hardip Patel, The Easteal Group, Genome Diversity and Health, JCSMR
12–1pm 30 June 2017
Professor Ricky Johnstone received his PhD from the University of Melbourne in 1993 and after a postdoc at Harvard Medical School returned to Melbourne to establish the Gene Regulation Laboratory at the Peter MacCallum Cancer...
2.10pm 26 June 2017
3.30–4.30pm 23 June 2017
Mr Yadollah Ranjbar Slamloo, The Arabzadeh Group, JCSMR, ANU
12–1pm 23 June 2017
Dr Amee George, Manager, ACRF Target and Drug Discovery Platform, JCSMR High throughput screening (HTS) is a way of rapidly assessing a large number of candidate compounds or genetic modulators to identify those which can...
12–1pm 16 June 2017
Dr Minni Änkö, Head - RNA Processing in Health and Disease Laboratory, Biomedicine Discovery Institute/Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC The life and function of RNA is...
12–1pm 14 June 2017
Extracellular matrix in beta cell health and diseases  Associate Professor Charmaine Simeonovic, The Simeonovic Group - Diabetes/Transplantation Immunology, JCSMR and Untangling the B cell response to Malaria...
3.30–4.30pm 9 June 2017
Angel Lu, Provis/Valter Group, The Eccles Institute of Neuroscience, JCSMR, ANU        
12–1pm 9 June 2017
Associate Professor Ross Laybutt, Garvan Institute of Medical Research, Sydney, NSW Type 2 diabetes arises in subjects with islet beta cells that are susceptible to dysfunction and death under conditions of high insulin demand...
3.30–4.30pm 8 June 2017
Dr Alexandra Hackmann, The Fischer Group - Epigenetics and Genome Stability, JCSMR Seminar will be followed by drinks in The Staff Tearoom.
12–1pm 5 June 2017
Genotype/Phenotype Relations of Nfkb2 in the Immune System Ainsley Davies, The Cook Group, Department of Immunology and Infectious Disease, JCSMR, ANU, and The Canberra Hospital and Using Noscapine Derivatives to...
12–1pm 2 June 2017
Professor Paul A Gleeson, Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC The Golgi apparatus is a highly dynamic organelle at...
12–1pm 31 May 2017
Role of Polycomb gene in immune responses  Dr Lisa Miosge, The Goodnow Group, JCSMR and Heparan Sulfate in T cell development  Dr David Simon Davis, The Parish Group, JCSMR
5.30–6.15pm 29 May 2017
Professor Joan Leach, Director, Australian National Centre for the Public Awareness of Science (CPAS), ANU The 1960s were a heady decade for ‘selling’ Big Science to global publics. Medical research was included in...
3.30–4.30pm 26 May 2017
Michael Lawrence G. Castanares, Daria Group, JCSMR      
12–1pm 26 May 2017
Dr WM (Steve) Lee, Senior Lecturer/ARC DECRA, ANU College of Engineering and Computer Science Since Antonie Leeuwenhoek and Robert Hooke opened our eyes to an animated world of microbes using polished lenses, light microscopy...
12–1pm 25 May 2017
Rohan Williams, Singapore Centre for Environmental Life Sciences Engineering, National University of Singapore Understanding the composition and function of complex microbial communities remains a key goal of applied microbial...
3.30–4.30am 25 May 2017
Dr Lee Wong, Monash University. Dr Lee Wong is a group leader at Monash University, Australia. Her long-standing research interest is to identify new chromatin factors that control chromosome stability and genetic...
12–1pm 24 May 2017
Henry Sutton, The Cockburn Group, JCSMR Does affinity determine Malaria Specific B cell Fate   Alicia Wilson, The Bruestle Group, JCSMR TBA 


Updated:  21 January 2018/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager